Weiqin Lin

1.0k total citations
57 papers, 531 citations indexed

About

Weiqin Lin is a scholar working on Cardiology and Cardiovascular Medicine, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Weiqin Lin has authored 57 papers receiving a total of 531 indexed citations (citations by other indexed papers that have themselves been cited), including 41 papers in Cardiology and Cardiovascular Medicine, 13 papers in Pulmonary and Respiratory Medicine and 10 papers in Surgery. Recurrent topics in Weiqin Lin's work include Heart Failure Treatment and Management (15 papers), Cardiovascular Function and Risk Factors (11 papers) and Cardiomyopathy and Myosin Studies (8 papers). Weiqin Lin is often cited by papers focused on Heart Failure Treatment and Management (15 papers), Cardiovascular Function and Risk Factors (11 papers) and Cardiomyopathy and Myosin Studies (8 papers). Weiqin Lin collaborates with scholars based in Singapore, United States and United Kingdom. Weiqin Lin's co-authors include Ching‐Hui Sia, Raymond Wong, Mark Y. Chan, Jamie Sin Ying Ho, Tiong‐Cheng Yeo, Nicholas Syn, Yao Neng Teo, Yao Hao Teo, Chi‐Hang Lee and Benjamin Yong‐Qiang Tan and has published in prestigious journals such as Journal of the American College of Cardiology, European Heart Journal and Critical Care Medicine.

In The Last Decade

Weiqin Lin

51 papers receiving 519 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Weiqin Lin Singapore 12 264 113 97 94 81 57 531
Oscar Hou In Chou Hong Kong 13 150 0.6× 168 1.5× 97 1.0× 96 1.0× 43 0.5× 56 500
Ebrahim Barkoudah United States 12 308 1.2× 105 0.9× 119 1.2× 42 0.4× 43 0.5× 36 525
Peter Jirak Austria 15 337 1.3× 36 0.3× 72 0.7× 102 1.1× 85 1.0× 52 690
Luca Bergamaschi Italy 15 489 1.9× 206 1.8× 182 1.9× 83 0.9× 160 2.0× 58 838
Jun Shitara Japan 16 351 1.3× 57 0.5× 206 2.1× 50 0.5× 34 0.4× 68 710
Krzysztof Ozierański Poland 16 531 2.0× 32 0.3× 92 0.9× 60 0.6× 71 0.9× 75 721
Samuel Spitalewitz United States 11 275 1.0× 175 1.5× 96 1.0× 55 0.6× 55 0.7× 24 643
Ahmet Duran Demir Türkiye 17 437 1.7× 39 0.3× 188 1.9× 45 0.5× 43 0.5× 81 792
Nikola Kozhuharov Switzerland 14 773 2.9× 48 0.4× 95 1.0× 57 0.6× 26 0.3× 61 943
Evelyn Santiago‐Vacas Spain 14 380 1.4× 100 0.9× 118 1.2× 85 0.9× 16 0.2× 45 571

Countries citing papers authored by Weiqin Lin

Since Specialization
Citations

This map shows the geographic impact of Weiqin Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Weiqin Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Weiqin Lin more than expected).

Fields of papers citing papers by Weiqin Lin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Weiqin Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Weiqin Lin. The network helps show where Weiqin Lin may publish in the future.

Co-authorship network of co-authors of Weiqin Lin

This figure shows the co-authorship network connecting the top 25 collaborators of Weiqin Lin. A scholar is included among the top collaborators of Weiqin Lin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Weiqin Lin. Weiqin Lin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Cheng, Ling Jie, et al.. (2025). Global prevalence of myocardial fibrosis among individuals with cardiometabolic conditions: a systematic review and meta-analysis. European Journal of Preventive Cardiology. 32(12). 1077–1091.
2.
3.
Sia, Ching‐Hui, et al.. (2024). Incidental finding of MELAS in a young woman with decompensated heart failure and end stage kidney disease: a case report. European Heart Journal - Case Reports. 9(1). ytae690–ytae690.
4.
5.
6.
Chew, Nicholas, Colin Yeo, Kevin Leong, et al.. (2023). Genomics in practice - a review of inherited cardiac conditions. 1 indexed citations
7.
Lin, Weiqin, et al.. (2023). The Role of Exercise-based Cardiac Rehabilitation in Heart Failure. Current Pharmaceutical Design. 29(7). 494–501. 1 indexed citations
8.
Sim, David, Weiqin Lin, Andrew Sindone, et al.. (2023). Asian Pacific Society of Cardiology Consensus Statements on the Diagnosis and Management of Chronic Heart Failure. 2. 7 indexed citations
9.
Lee, Ainsley Ryan Yan Bin, Chun En Yau, Jiaqi Li, et al.. (2023). Natural Progression of Left Ventricular Function following Anthracyclines without Cardioprotective Therapy: A Systematic Review and Meta-Analysis. Cancers. 15(2). 512–512. 11 indexed citations
10.
Lin, Weiqin, Pairoj Chattranukulchai, Alex Pui‐Wai Lee, et al.. (2022). Clinical recommendations to diagnose and monitor patients with transthyretin amyloid cardiomyopathy in Asia. Clinical Cardiology. 45(9). 898–907. 4 indexed citations
11.
Wong, Raymond, Ping Chai, Ching‐Hui Sia, et al.. (2022). Utility and pitfalls of the electrocardiogram in the evaluation of cardiac amyloidosis. Annals of Noninvasive Electrocardiology. 27(4). e12967–e12967. 13 indexed citations
12.
Lin, Weiqin, et al.. (2022). Ventricular tachycardia from myocarditis following COVID‐19 vaccination with tozinameran (BNT162b2, Pfizer‐BioNTech). Pacing and Clinical Electrophysiology. 45(9). 1097–1100. 5 indexed citations
13.
Ling, Ryan Ruiyang, Chuen Seng Tan, Shir Lynn Lim, et al.. (2022). Microaxial Left Ventricular Assist Device in Cardiogenic Shock: A Systematic Review and Meta-Analysis. Life. 12(10). 1629–1629. 5 indexed citations
14.
Ho, Jamie Sin Ying, Mark Y. Chan, Ping Chai, et al.. (2022). Prevalence and Risk Factors of Cardiac Amyloidosis in Heart Failure: A Systematic Review and Meta-Analysis. Heart Lung and Circulation. 31(11). 1450–1462. 17 indexed citations
15.
Teo, Yao Hao, Yao Neng Teo, Nicholas Syn, et al.. (2022). Evaluating the Initiation of Sodium/Glucose Cotransporter 2 Inhibitors within 2 Weeks of an Acute Hospital Admission: A Systematic Review and Meta-Analysis of Nine Clinical Trials. Medical Principles and Practice. 31(3). 215–223. 3 indexed citations
16.
Lee, Ainsley Ryan Yan Bin, Chun En Yau, Jiaqi Li, et al.. (2022). Natural Progression of Left Ventricular Function Following Anthracyclines without Cardioprotective Therapy: A Systematic Review and Meta-Analysis. Preprints.org. 2 indexed citations
17.
Teo, Yao Neng, Yao Hao Teo, Nicholas Syn, et al.. (2022). Prevalence and incidence of cognitive impairment and dementia in heart failure – A systematic review, meta-analysis and meta-regression. Hellenic Journal of Cardiology. 67. 48–58. 21 indexed citations
18.
Teo, Yao Hao, Yao Neng Teo, Nicholas Syn, et al.. (2021). Effects of Sodium/Glucose Cotransporter 2 (SGLT2) Inhibitors on Cardiovascular and Metabolic Outcomes in Patients Without Diabetes Mellitus: A Systematic Review and Meta‐Analysis of Randomized‐Controlled Trials. Journal of the American Heart Association. 10(5). e019463–e019463. 79 indexed citations
19.
Lin, Weiqin, Sen Hee Tay, & Anselm Mak. (2020). Takotsubo syndrome and rheumatic diseases—a critical systematic review. Lara D. Veeken. 60(1). 11–22. 9 indexed citations
20.
Ibrahim, Irwani, Win Sen Kuan, Chris Frampton, et al.. (2016). Superior Performance of N-Terminal Pro Brain Natriuretic Peptide for Diagnosis of Acute Decompensated Heart Failure in an Asian Compared with a Western Setting. European Journal of Heart Failure. 19(2). 209–217. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Oscar Hou In Chou Breakdown of academic impact, for papers by Ebrahim Barkoudah Breakdown of academic impact, for papers by Peter Jirak Breakdown of academic impact, for papers by Luca Bergamaschi Breakdown of academic impact, for papers by Jun Shitara Breakdown of academic impact, for papers by Krzysztof Ozierański Breakdown of academic impact, for papers by Samuel Spitalewitz Breakdown of academic impact, for papers by Ahmet Duran Demir Breakdown of academic impact, for papers by Nikola Kozhuharov Breakdown of academic impact, for papers by Evelyn Santiago‐Vacas
Rankless by CCL
2026